Molecular detection of micro-metastasis in breast cancer

Critical Reviews in Oncology/Hematology

Volumn 43, Issue 1, 2002, Pages 13-31

  Jiang, Wen G ^a   Martin, Tracey A ^a   Mansel, Robert E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bone marrow; Breast cancer; Micro metastasis; Polymerase chain reaction; Sentinel node

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; COLLAGEN TYPE 1; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLOBIN; GLYCOPROTEIN GP 100; GUANYLATE CYCLASE; MAMMAGLOBIN; MASPIN; MATRILYSIN; MELAN A; MOLECULAR MARKER; MONOPHENOL MONOOXYGENASE; MUCIN; MUCIN 1; PARATHYROID HORMONE; PROLACTIN; PROTEIN P97; PROTEIN S 100; TELOMERASE; UNCLASSIFIED DRUG; VILLIN;

BONE MARROW; BREAST CARCINOMA; CANCER CELL; CANCER DIAGNOSIS; CELL ASSAY; CLINICAL TRIAL; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; METHYLATION; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; ONCOGENE C ERB; POLYMERASE CHAIN REACTION; PROGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE;

BONE MARROW; BREAST NEOPLASMS; HUMANS; LYMPH NODES; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS;

EID: 0036298299     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00181-0     Document Type: Review

References (141)

1. What is the evidence that tumors are angiogenesis dependent?
2. Molecular aspects of the metastatic cascade
3. The molecular and cellular basis of cancer invasion and metastasis and its implications for treatment
4. The bone marrow examination in breast cancer: Diagnositic considerations and clinical usefulness
5. Incidence and histopathology of metastases of mammry carcinoma in biopsies form the posterior iliac crest
6. Detection and clinical importance of micrometastatic disease
7. Bone marrow micrometastases detection and significance
8. Meta-analysis of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated
9. Molecular detection of low level disease in patients with cancer
10. Detection and management of bone marrow micrometastases in breast cancer
11. Micrometastasis detection and treatment with monoclonal antibodies
12. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction
13. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence
14. Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells
15. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma
16. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: Correlation with established prognostic parameters
17. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
18. Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer
19. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR
20. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cellsin combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19
21. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma
22. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer
23. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: Validation by K-RAS mutations
24. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction
25. Expression of mucins and cytokeratins in ovarian cancer cell lines
26. Detection of circulating tumor cells and micrometastases in stage II, III, and IV breast cancer patients utilizing cytology and immunocytochemistry
27. Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers
28. RT-PCR detection of breast cancer cells in sentinel lymph modes
29. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: A pilot study
30. Clinical significance of micrometastases in axillary lymph nodes assessed by reversion transcription polymerase chain reaction in breast cancer patients
31. Detection of MUC1 expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real time polymerase chain reaction
32. Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction
33. Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma
34. Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer
35. Illegitimate villin transcripts in normal bone marrow preclude detection of colon cancer micrometastases
36. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy
37. Mucin gene expression in normal and neoplastic tissue and the use of mucin mRNAs as markers for micrometastatic disease
38. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes
39. Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients
40. Assessment of Stanniocalcin-1 mRNA, as a molecular marker for micrometastases of various human cancers
41. Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy
42. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein
43. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma
44. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer
45. The potential role far prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis
46. Tumor markers in peripheral blood of patients with malignant melanoma: Multimarker RT-PCR versus a luminoimmunometric assay for S-100
47. Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes
48. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: A quality control study using real-time quantitative RT-PCR
49. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction
50. Detection of the pancreas-specific gene in the peripheral blood of patients with pancreatic carcinoma
51. Mapping of occult melanoma micrometastases in the inguinal lymph node basin by immunohistochemistry and RT-PCR
52. A seminested RT-PCR assay for HER2/neu: Initial validation of a new method for the detection of disseminated breast cancer cells
53. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription polymerase chain reaction for epidermal growth factor receptor
54. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor
55. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin
56. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer
57. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction
58. Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood
59. Sensitive nested reverse transcription plolymerase chain reaction of circulating prostatic tumor cells
60. Molecular detection of GAGE expression in peripheral blood and bone marrow
61. The detection of breast-carcinoma micrometastases in axillary lymph-nodes by means ofreverse-transcriptase polymerase chain-reaction
62. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction - Comparison between MUC1 mRNA and keratin 19 mRNA amplification
63. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase polymerase chain reaction
64. Human prostatic carcinoma PYI-1 is expressed in human blood tumor cell lines and prostate carcinoma patient blood samples
65. Coombes Rc detection of breast-cancer micrometastases in axillary lymph-nodes by using polymerase chain-reaction
66. Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients
67. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19
68. Mammaglobin expression in primary, metastatic, and occult breast cancer
69. Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients
70. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction
71. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel
72. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients
73. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
74. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically netative lymph nodes
75. Sentinel lymphadenectomy in breast cancer
76. History, present status and future of sentinel node biopsy in breast cancer
77. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease
78. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph node
79. Implications of prostate micrometastases in pelvic lymph nodes: An archival tissue study
80. Improved method for mRNA extraction from paraffin-embedded tissues
81. Sonification as a means of enhancing the detection of gene expression levels form formalin-fixed paraffin embedded biopsies
82. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real time polymerase chain reaction
83. Clonality analysis of defined cell population in paraffin embedded tissue sections by RT-PCR amplification of X-linked G6PD gene
84. Sensitive detection o foccult Ewings cells by the reversion transcriptionase polymerase chain reaction
85. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells
86. Expression genetics in cancer: Shifting the focus from DNA to RNA
87. Maspin: A tumor suppressing serpin
88. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells
89. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin
90. Production, purification, and characterization of recombinant maspin proteins
91. Gamma linolenic acid selectively regulates the expression maspin and motility of cancer cells
92. Function of maspin
93. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene
94. Detection of breast cancer cells in blood using immunomagnetic bead selection and reverse transcription polymerase chain reaction
95. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplificationfor the detection of circulating breast cancer cells
96. Sensitive and quantitative one-step polymerase chain reaction using capillary electrophoresis and fluorescence detection for measuring cytokeratin 19 expression
97. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: Comparison of quantitative polymerase chain reaction and immunocytochemical techniques
98. Detection of circulating thyroid cells in peripheral blood
99. Detection of thyroid peroxidase and RET/PTC mRNA in the peripheral blood of patients with thyroid diseases
100. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients
101. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA
102. Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer
103. Molecular detection of micrometastasis and circulating cells in solid tumors
104. Bone scintiscanning in the initial assessment of carcinoma of the breast
105. Efficacy of preoperative and post-operative bone scanning in the management of breast carcinoma
106. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen
107. Micrometastatic cancer cells in bone marrow
108. Fluorescent monoclonal antibody detection of occult micrometastases in the bone marrow
109. The clinical study of micrometastatic cancer by bone biopsy
110. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases
111. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation
112. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19
113. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients
114. Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients
115. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products
116. Microsatellite alterations in plasma DNA of primary breast cancer patients
117. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients
118. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA
119. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro
120. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes
121. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells
122. MUC1 expression in hematopoietic tissues
123. Detection of micrometastasis and circulating tumour cells using molecular biology technicks in solid tumours
124. Reverse transcriptase polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: A sensitive method for monitoring purging efficiency
125. Immunobead RT-PCR: A sensitive method for detection of circulating tumor cells
126. Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: A new sensitive one step method without false positive results
127. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients
128. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors
129. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy
130. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers
131. High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood
132. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel
133. Detection of circulating breast cancer cells with multiple-marker RT-PCR assay
134. Clinical significance of circulating cancer cells in peripheral blood detected by reverse transcriptase-polymerase chain reaction in patients with breast cancer
135. Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction
136. Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells
137. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins
138. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast and bladder cancers
139. Detection of breast cancer cells in ductal lavage fluid by methylation specific PCR
140. Tumour spread-the problems of latency